Should any medications be discontinued prior to a colonoscopy?

Medication Management Prior to Colonoscopy

Yes, certain medications must be discontinued prior to colonoscopy, but the specific medications and timing depend on the bleeding risk of the procedure and the patient's thromboembolic risk. The 2025 US Multi-Society Task Force guidelines emphasize that the bowel preparation process includes instructions on "what medications to hold" as a core component 1.

Key Medication Categories Requiring Consideration

Anticoagulants and Antiplatelet Agents

For high-risk bleeding procedures (polypectomy, sphincterotomy, mucosal ablation):

• Warfarin: Discontinue 4-5 days before the procedure, targeting INR ≤1.5 2. Can generally resume the evening of the procedure 3.

• Clopidogrel (Plavix): Hold for 7 days prior to colonoscopy with anticipated polypectomy 3, 2.

• Aspirin and NSAIDs: Do NOT need to be discontinued for colonoscopy with or without polypectomy 4. Multiple studies demonstrate no significant increase in postpolypectomy bleeding risk when aspirin/NSAIDs are continued (bleeding rate 3.2% vs 3.0% in non-users) 4. The number of polyps removed is the only significant risk factor for bleeding, not aspirin/NSAID use 4.

• Direct oral anticoagulants (DOACs): Due to rapid onset/offset, periprocedural bridging is generally not necessary 5. Hold for appropriate duration based on half-life and renal function.

Critical Caveat on Aspirin

Despite evidence supporting continuation, only 43.5% of US endoscopy units routinely continue aspirin before colonoscopy 6. The most common reasons for unnecessary discontinuation include unfounded concern about bleeding (62%), perceived minimal downside to stopping (38%), and inertia (20%) 6. This practice contradicts evidence and potentially increases thromboembolic risk.

GLP-1 Receptor Agonists

These medications delay gastric emptying and require special consideration 1. The American Society of Anesthesiologists recommends stopping GLP-1 agonists for 1-7 days (agent-dependent) before elective procedures to limit aspiration risk during sedation 1. However, the American Gastroenterology Association suggests case-by-case decision-making 1.

Timing consideration: When using same-day or split-dose bowel preparation, patients should complete the purgative at least 2 hours before procedure start to minimize aspiration risk 1.

Risk Stratification Approach

Low-risk procedures (diagnostic colonoscopy with biopsy only): No anticoagulation adjustment necessary 2.

High-risk procedures (polypectomy, therapeutic interventions):

• Assess patient's thromboembolic risk based on underlying condition
• High thromboembolic risk patients may require bridging with heparin when warfarin is held 2
• Consider vitamin K or fresh frozen plasma if urgent normalization of INR is needed 2

Bowel Preparation Regimen Selection

The guidelines recommend selecting a bowel preparation regimen that considers the individual's medical history and medications (strong recommendation, moderate-quality evidence) 1. Specifically, avoid hyperosmotic regimens in patients at risk for volume overload or electrolyte disturbances 1.

Common Pitfalls to Avoid

1. Unnecessarily stopping aspirin/NSAIDs: This increases thromboembolic risk without reducing bleeding risk 4
2. Failing to assess thromboembolic risk: Patients with mechanical heart valves, recent stents, or atrial fibrillation with high CHADS2 scores require careful bridging strategies 5
3. Not accounting for GLP-1 agonists: These increasingly common medications require specific timing considerations 1
4. Resuming anticoagulation too early: While warfarin can typically resume the evening of the procedure, individual bleeding risk should be considered 3